pI: 4.6551 |
Length (AA): 553 |
MW (Da): 61203 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 4 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
79 | 188 | 2lcq (A) | 7 | 107 | 24.00 | 0.00000000013 | 0.99 | 0.489115 | -0.41 |
216 | 277 | 5hhe (D) | 176 | 237 | 19.00 | 0 | 0.02 | 0.464016 | -2.11 |
236 | 360 | 5cwn (A) | 4 | 137 | 30.00 | 0.79 | 0.58 | 0.62574 | -1.18 |
389 | 460 | 2con (A) | 8 | 72 | 34.00 | 0.00086 | 0.95 | 0.327899 | 0.91 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | VEG Tachyzoite, ME49 merozoite, ME49 Oocyst, ME49 Bradyzoite. | Gregory Hehl AB Fritz HM Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | ME49 Tachyzoite. | Gregory |
Gregory | ToxoDB |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Sibley/Greg | ToxoDB |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Ortholog group members (OG5_128403)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT5G41190 | RNA-binding protein NOB1 |
Babesia bovis | BBOV_IV004230 | conserved hypothetical protein |
Brugia malayi | Bm1_41880 | nin one binding protein |
Candida albicans | CaO19.6955 | similar to Nin1 binding protein, chaperone of the 26S proteasome |
Candida albicans | CaO19.14217 | similar to Nin1 binding protein, chaperone of the 26S proteasome |
Caenorhabditis elegans | CELE_Y54E10BR.4 | Protein Y54E10BR.4 |
Cryptosporidium hominis | Chro.70180 | CG2972 gene product |
Cryptosporidium parvum | cgd7_1530 | ART-4 protein; PIN+Zn ribbon domains. involved in RNA metabolism |
Dictyostelium discoideum | DDB_G0279821 | hypothetical protein |
Drosophila melanogaster | Dmel_CG2972 | CG2972 gene product from transcript CG2972-RB |
Echinococcus granulosus | EgrG_001130100 | RNA binding protein NOB1 |
Entamoeba histolytica | EHI_087710 | hypothetical protein, conserved |
Echinococcus multilocularis | EmuJ_001130100 | RNA binding protein NOB1 |
Giardia lamblia | GL50803_34141 | Nin one binding protein-like protein |
Homo sapiens | ENSG00000141101 | NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.35.5310 | hypothetical protein, conserved |
Leishmania donovani | LdBPK_365290.1 | Nin one binding (NOB1) Zn-ribbon like, putative |
Leishmania infantum | LinJ.36.5290 | hypothetical protein, conserved |
Leishmania major | LmjF.36.5060 | hypothetical protein, conserved |
Leishmania mexicana | LmxM.36.5060 | hypothetical protein, conserved |
Loa Loa (eye worm) | LOAG_05582 | nin one binding protein |
Mus musculus | ENSMUSG00000003848 | NIN1/RPN12 binding protein 1 homolog (S. cerevisiae) |
Neospora caninum | NCLIV_061710 | hypothetical protein, conserved |
Oryza sativa | 4328064 | Os02g0114700 |
Plasmodium berghei | PBANKA_0720800 | RNA-binding protein NOB1, putative |
Plasmodium falciparum | PF3D7_0418700 | RNA-binding protein NOB1, putative |
Plasmodium knowlesi | PKNH_0511400 | RNA-binding protein NOB1, putative |
Plasmodium vivax | PVX_090025 | RNA-binding protein NOB1, putative |
Plasmodium yoelii | PY05599 | Drosophila melanogaster CG2972 gene product |
Saccharomyces cerevisiae | YOR056C | Nob1p |
Schistosoma japonicum | Sjp_0302360 | ko:K07060 NOB1, LOC489733; NIN1/RPN12 binding protein 1 homolog, putative |
Schistosoma mansoni | Smp_064510 | rna-binding protein nob1 |
Schmidtea mediterranea | mk4.000363.04 | RNA-binding protein NOB1 |
Trypanosoma brucei gambiense | Tbg972.11.12170 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.11.10860 | 20S-pre-rRNA D-site endonuclease NOB1 |
Trypanosoma congolense | TcIL3000.11.11530 | Nin one binding (NOB1) Zn-ribbon like, putative |
Trypanosoma cruzi | TcCLB.510423.40 | Nin one binding (NOB1) Zn-ribbon like, putative |
Toxoplasma gondii | TGME49_218570 | Nin one binding (NOB1) Zn-ribbon family protein |
Theileria parva | TP01_0331 | hypothetical protein, conserved |
Trichomonas vaginalis | TVAG_151710 | RNA-binding protein nob1, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb11.01.2630 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb11.01.2630 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb11.01.2630 | Trypanosoma brucei | significant gain of fitness in procyclic forms | alsford |
Tb11.01.2630 | Trypanosoma brucei | no significant loss or gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_Y54E10BR.4 | Caenorhabditis elegans | larval arrest | wormbase |
CELE_Y54E10BR.4 | Caenorhabditis elegans | slow growth | wormbase |
YOR056C | Saccharomyces cerevisiae | inviable | yeastgenome |
PBANKA_0720800 | Plasmodium berghei | Essential | plasmo |
TGME49_218570 this record | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.